{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:01:27Z","timestamp":1787068887427,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10528-024-10928-w","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:01:53Z","timestamp":1727827313000},"page":"4304-4330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Novel Mitochondrial-Related Gene Signature for the Prediction of Prognosis and Therapeutic Efficacy in Lower-Grade Glioma"],"prefix":"10.1007","volume":"63","author":[{"given":"Jingyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqiao","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiansheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songshan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"issue":"19","key":"10928_CR1","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/1078-0432.CCR-19-3255","volume":"26","author":"JC Benitez","year":"2020","unstructured":"Benitez JC, Remon J, Besse B (2020) Current panorama and challenges for neoadjuvant cancer immunotherapy. Clin Cancer Res 26(19):5068\u20135077","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10928_CR2","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S1470-2045(20)30328-4","volume":"21","author":"S Billan","year":"2020","unstructured":"Billan S, Kaidar-Person O, Gil Z (2020) Treatment after progression in the era of immunotherapy. Lancet Oncol 21(10):e463\u2013e476","journal-title":"Lancet Oncol"},{"key":"10928_CR3","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101255","volume":"26","author":"C Breda","year":"2019","unstructured":"Breda C, Davanzo GG, Basso PJ, Saraiva CN, Moraes-Vieira P (2019) Mitochondria as central hub of the immune system. Redox Biol 26:101255","journal-title":"Redox Biol"},{"key":"10928_CR4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2022.127082","volume":"74","author":"X Chen","year":"2022","unstructured":"Chen X, Fu G, Li L, Zhao Q, Ke Z, Zhang R (2022) Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma. J Trace Elem Med Biol 74:127082","journal-title":"J Trace Elem Med Biol"},{"issue":"4","key":"10928_CR5","doi-asserted-by":"crossref","first-page":"ar29","DOI":"10.1091\/mbc.E21-03-0143","volume":"33","author":"KJ Chojnacka","year":"2022","unstructured":"Chojnacka KJ, Elancheliyan P, Mussulini B, Mohanraj K, Callegari S, Gosk A et al (2022) Ovarian carcinoma immunoreactive antigen-like protein 2 (OCIAD2) is a novel complex III-specific assembly factor in mitochondria. Mol Biol Cell 33(4):ar29","journal-title":"Mol Biol Cell"},{"issue":"10","key":"10928_CR6","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/gb-2012-13-10-r95","volume":"13","author":"A Decock","year":"2012","unstructured":"Decock A, Ongenaert M, Hoebeeck J, De Preter K, Van Peer G, Van Criekinge W et al (2012) Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers. Genome Biol 13(10):R95","journal-title":"Genome Biol"},{"issue":"5","key":"10928_CR7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/aps.2011.16","volume":"32","author":"WH Fan","year":"2011","unstructured":"Fan WH, Hou Y, Meng FK, Wang XF, Luo YN, Ge PF (2011) Proteasome inhibitor MG-132 induces C6 glioma cell apoptosis via oxidative stress. Acta Pharmacol Sin 32(5):619\u2013625","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"10928_CR8","first-page":"4845","volume":"29","author":"T Fukushima","year":"2009","unstructured":"Fukushima T, Takeshima H, Kataoka H (2009) Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. Anticancer Res 29(11):4845\u20134854","journal-title":"Anticancer Res"},{"key":"10928_CR9","doi-asserted-by":"crossref","unstructured":"Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):D1049\u2013D1056","DOI":"10.1093\/nar\/gku1179"},{"issue":"7757","key":"10928_CR10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jane-Valbuena J, Kryukov GV, Lo CC, McDonald ER et al (2019) Next-generation characterization of the cancer cell line encyclopedia. Nature 569(7757):503\u2013508","journal-title":"Nature"},{"key":"10928_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform 14:7","journal-title":"BMC Bioinform"},{"issue":"1","key":"10928_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41419-018-1242-1","volume":"10","author":"P Hu","year":"2019","unstructured":"Hu P, Li S, Tian N, Wu F, Hu Y, Li D et al (2019) Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D. Cell Death Dis 10(1):25","journal-title":"Cell Death Dis"},{"key":"10928_CR13","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1038\/ncomms7750","volume":"6","author":"KJ Jang","year":"2015","unstructured":"Jang KJ, Mano H, Aoki K, Hayashi T, Muto A, Nambu Y et al (2015) Mitochondrial function provides instructive signals for activation-induced B-cell fates. Nat Commun 6:6750","journal-title":"Nat Commun"},{"issue":"10","key":"10928_CR14","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558","journal-title":"Nat Med"},{"issue":"5","key":"10928_CR15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Chen M, Nie H, Yuan Y (2019) PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vacc Immunother 15(5):1111\u20131122","journal-title":"Hum Vacc Immunother"},{"issue":"9","key":"10928_CR16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582\u2013598","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10928_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27\u201330","journal-title":"Nucleic Acids Res"},{"key":"10928_CR18","volume":"11","author":"K Klein","year":"2020","unstructured":"Klein K, He K, Younes AI, Barsoumian HB, Chen D, Ozgen T et al (2020) Role of mitochondria in cancer immune evasion and potential therapeutic approaches. Front Immunol 11:573326","journal-title":"Front Immunol"},{"key":"10928_CR19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107922","volume":"228","author":"F Lang","year":"2021","unstructured":"Lang F, Liu Y, Chou FJ, Yang C (2021) Genotoxic therapy and resistance mechanism in gliomas. Pharmacol Therapeut 228:107922","journal-title":"Pharmacol Therapeut"},{"issue":"10145","key":"10928_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392(10145):432\u2013446","journal-title":"Lancet"},{"issue":"5","key":"10928_CR21","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.21037\/tcr.2020.04.16","volume":"9","author":"S Li","year":"2020","unstructured":"Li S, Wang W, Zi J, Sun M, Mei W, Yang N et al (2020) Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset. Transl Cancer Res 9(5):3610\u20133622","journal-title":"Transl Cancer Res"},{"issue":"2","key":"10928_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0304-3835(96)04276-0","volume":"105","author":"BC Liang","year":"1996","unstructured":"Liang BC, Hays L (1996) Mitochondrial DNA copy number changes in human gliomas. Cancer Lett 105(2):167\u2013173","journal-title":"Cancer Lett"},{"issue":"8","key":"10928_CR23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251","journal-title":"Neuro Oncol"},{"issue":"4","key":"10928_CR24","first-page":"868","volume":"7","author":"RM Maas","year":"2001","unstructured":"Maas RM, Reus K, Diesel B, Steudel WI, Feiden W, Fischer U et al (2001) Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1, alpha-hydroxylase (CYP 27B1) in human malignant glioma. Clin Cancer Res 7(4):868\u2013875","journal-title":"Clin Cancer Res"},{"key":"10928_CR25","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 22(6)","DOI":"10.1093\/bib\/bbab260"},{"issue":"5","key":"10928_CR26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12(5):453\u2013457","journal-title":"Nat Methods"},{"key":"10928_CR27","doi-asserted-by":"crossref","unstructured":"Niogret J, Berger H, Rebe C, Mary R, Ballot E, Truntzer C et al (2021) Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1\/PD-1 efficacy. J Immunother Cancer 9(6)","DOI":"10.1136\/jitc-2020-002157"},{"issue":"6","key":"10928_CR28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148(6):1145\u20131159","journal-title":"Cell"},{"issue":"1","key":"10928_CR29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12035-010-8133-5","volume":"42","author":"BB Ordys","year":"2010","unstructured":"Ordys BB, Launay S, Deighton RF, McCulloch J, Whittle IR (2010) The role of mitochondria in glioma pathophysiology. Mol Neurobiol 42(1):64\u201375","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10928_CR30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ (2016) Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol 173(4):649\u2013665","journal-title":"Br J Pharmacol"},{"key":"10928_CR31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semcancer.2017.12.011","volume":"56","author":"A Poff","year":"2019","unstructured":"Poff A, Koutnik AP, Egan KM, Sahebjam S, D\u2019Agostino D, Kumar NB (2019) Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Semin Cancer Biol 56:135\u2013148","journal-title":"Semin Cancer Biol"},{"issue":"10031","key":"10928_CR32","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg JE, Hoffman-Censits J, Powles T, van der Heijden MS, Balar AV, Necchi A et al (2016) Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet 387(10031):1909\u20131920","journal-title":"Lancet"},{"key":"10928_CR33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mito.2017.11.005","volume":"41","author":"H Sandoval","year":"2018","unstructured":"Sandoval H, Kodali S, Wang J (2018) Regulation of B cell fate, survival, and function by mitochondria and autophagy. Mitochondrion 41:58\u201365","journal-title":"Mitochondrion"},{"issue":"7","key":"10928_CR34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/neuonc\/noz033","volume":"21","author":"D Schiff","year":"2019","unstructured":"Schiff D, Van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M et al (2019) Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus. Neuro Oncol 21(7):837\u2013853","journal-title":"Neuro Oncol"},{"issue":"2","key":"10928_CR35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trecan.2020.09.007","volume":"7","author":"A Schrempf","year":"2021","unstructured":"Schrempf A, Slyskova J, Loizou JI (2021) Targeting the DNA repair enzyme polymerase theta in cancer therapy. Trends Cancer 7(2):98\u2013111","journal-title":"Trends Cancer"},{"issue":"11","key":"10928_CR36","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","volume":"5","author":"B Seashore-Ludlow","year":"2015","unstructured":"Seashore-Ludlow B, Rees MG, Cheah JH, Cokol M, Price EV, Coletti ME et al (2015) Harnessing connectivity in a large-scale small-molecule sensitivity dataset. Cancer Discov 5(11):1210\u20131223","journal-title":"Cancer Discov"},{"issue":"9","key":"10928_CR37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1468-1331.2010.03151.x","volume":"17","author":"R Soffietti","year":"2010","unstructured":"Soffietti R, Baumert BG, Bello L, Von Deimling A, Duffau H, Frenay M et al (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17(9):1124\u20131133","journal-title":"Eur J Neurol"},{"issue":"43","key":"10928_CR38","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10928_CR39","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/1541-7786.MCR-12-0168","volume":"10","author":"D Svilar","year":"2012","unstructured":"Svilar D, Dyavaiah M, Brown AR, Tang JB, Li J, McDonald PR et al (2012) Alkylation sensitivity screens reveal a conserved cross-species functionome. Mol Cancer Res 10(12):1580\u20131596","journal-title":"Mol Cancer Res"},{"issue":"3","key":"10928_CR40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","volume":"120","author":"MJ van den Bent","year":"2010","unstructured":"van den Bent MJ (2010) Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician\u2019s perspective. Acta Neuropathol 120(3):297\u2013304","journal-title":"Acta Neuropathol"},{"key":"10928_CR41","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, Dai Z, Zheng L, Xu B, Zhang H, Fan F et al (2021) Ferroptosis activation scoring model assists in chemotherapeutic agents\u2019 selection and mediates cross-talk with immunocytes in malignant glioblastoma. Front Immunol 12:747408","journal-title":"Front Immunol"},{"issue":"1","key":"10928_CR42","first-page":"125","volume":"41","author":"PF Xu","year":"2019","unstructured":"Xu PF, Yang JA, Liu JH, Yang X, Liao JM, Yuan FE et al (2019) PI3Kbeta inhibitor AZD6482 exerts antiproliferative activity and induces apoptosis in human glioblastoma cells. Oncol Rep 41(1):125\u2013132","journal-title":"Oncol Rep"},{"issue":"8","key":"10928_CR43","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al (2009) IDH1 and IDH2 mutations in gliomas. New Engl J Med 360(8):765\u2013773","journal-title":"New Engl J Med"},{"key":"10928_CR44","doi-asserted-by":"crossref","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S et al (2013) Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41(Database issue):D955\u2013D961","DOI":"10.1093\/nar\/gks1111"},{"issue":"23","key":"10928_CR45","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1111\/jcmm.17021","volume":"25","author":"RH Yang","year":"2021","unstructured":"Yang RH, Liang B, Li JH, Pi XB, Yu K, Xiang SJ et al (2021) Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma. J Cell Mol Med 25(23):10990\u201311001","journal-title":"J Cell Mol Med"},{"key":"10928_CR46","first-page":"3370727","volume":"2022","author":"Y Yang","year":"2022","unstructured":"Yang Y, Tian Y, Li Q, Jiang R, Zhang J (2022) Uncovering the immune cell infiltration landscape in low-grade glioma for aiding immunotherapy. J Oncol 2022:3370727","journal-title":"J Oncol"},{"key":"10928_CR47","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3389\/fonc.2020.01409","volume":"10","author":"W Yin","year":"2020","unstructured":"Yin W, Jiang X, Tan J, Xin Z, Zhou Q, Zhan C et al (2020) Development and validation of a tumor mutation burden-related immune prognostic model for lower-grade glioma. FroNt Oncol 10:1409","journal-title":"FroNt Oncol"},{"key":"10928_CR48","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612","journal-title":"Nat Commun"},{"key":"10928_CR49","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xiao X, Wang Y, Song T, Li C, Bao H et al (2022) Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma. Front Genet 13:899125","journal-title":"Front Genet"},{"issue":"1","key":"10928_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang KN, Wang Q, Li G, Zeng F, Zhang Y et al (2021) Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from chinese glioma patients. Genom Proteom Bioinform 19(1):1\u201312","journal-title":"Genom Proteom Bioinform"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10928-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10928-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10928-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:13:29Z","timestamp":1758957209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10928-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10928"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10928-w","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"16 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}